卡尔-T细胞的细胞毒性反应迅速产生,对未结合的TCR敏感
bioRxiv : the preprint server for biology
|August 6, 2025
概括
化学抗原受体 (CAR) T细胞表现出强大的杀癌能力. 新的研究揭示了CAR T细胞激活是敏感的,类似于T细胞受体,涉及交叉通话,为改进的癌症治疗提供了洞察力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 化学抗原受体 (CAR) T细胞是为癌症治疗而设计的免疫细胞.
- 虽然在血液癌症中有效,但CAR T细胞在固体瘤中的有效性是有限的.
- 了解CAR T细胞激活机制对于优化其治疗潜力至关重要.
研究的目的:
- 研究CAR T细胞触发和激活值的分子机制.
- 阐明结合相互作用和受体交叉在CAR T细胞功能中的作用.
- 确定增强CAR T细胞疗效和减少癌症治疗中毒性的策略.
主要方法:
- 量化导致细胞毒性颗粒输送的CAR结合相互作用.
- 在单分子水平上对CAR T细胞激活的分析.
- 通过使用抑制性来研究CAR和本地T细胞受体 (TCR) 之间的交叉.
主要成果:
- 卡尔-T细胞表现出二元化细胞毒性活动,其中一组细胞主导着人口结果.
- 单分子激活 CAR T 细胞的敏感性与原生 TCRs 相当.
- 不结合的TCR信号的破坏显著抑制了CAR T细胞的激活,突出显示了受体交叉声.
结论:
- 卡尔-T细胞激活是一个敏感的过程,受多个结合事件的整合影响.
- TCR-CAR交叉是CAR T细胞反应的一个关键因素.
- 调节CAR T细胞信号整合和受体交叉通话是改善癌症免疫疗法的关键.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
T Cell Activation and Clonal Selection
4.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.7K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Cell-mediated Immune Responses
72.7K
Overview
72.7K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Antigens Involved in Adaptive Immunity
672
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
672


